Symposium 2024 day 4 centered around on OGM’s potential to serve as a genomic integrity tool for cell and gene therapy applications, supporting the development of in vivo gene therapies. Six Panelists will cover OGM’s ability to screen cell lines for genomic instability and off-target events associated with genome editing.